File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Modulation of oxidative stress as an anticancer strategy

TitleModulation of oxidative stress as an anticancer strategy
Authors
Issue Date2013
Citation
Nature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 931-947 How to Cite?
AbstractThe regulation of oxidative stress is an important factor in both tumour development and responses to anticancer therapies. Many signalling pathways that are linked to tumorigenesis can also regulate the metabolism of reactive oxygen species (ROS) through direct or indirect mechanisms. High ROS levels are generally detrimental to cells, and the redox status of cancer cells usually differs from that of normal cells. Because of metabolic and signalling aberrations, cancer cells exhibit elevated ROS levels. The observation that this is balanced by an increased antioxidant capacity suggests that high ROS levels may constitute a barrier to tumorigenesis. However, ROS can also promote tumour formation by inducing DNA mutations and pro-oncogenic signalling pathways. These contradictory effects have important implications for potential anticancer strategies that aim to modulate levels of ROS. In this Review, we address the controversial role of ROS in tumour development and in responses to anticancer therapies, and elaborate on the idea that targeting the antioxidant capacity of tumour cells can have a positive therapeutic impact. © 2013 Macmillan Publishers Limited.
Persistent Identifierhttp://hdl.handle.net/10722/292791
ISSN
2023 Impact Factor: 122.7
2023 SCImago Journal Rankings: 22.399
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorGorrini, Chiara-
dc.contributor.authorHarris, Isaac S.-
dc.contributor.authorMak, Tak W.-
dc.date.accessioned2020-11-17T14:57:13Z-
dc.date.available2020-11-17T14:57:13Z-
dc.date.issued2013-
dc.identifier.citationNature Reviews Drug Discovery, 2013, v. 12, n. 12, p. 931-947-
dc.identifier.issn1474-1776-
dc.identifier.urihttp://hdl.handle.net/10722/292791-
dc.description.abstractThe regulation of oxidative stress is an important factor in both tumour development and responses to anticancer therapies. Many signalling pathways that are linked to tumorigenesis can also regulate the metabolism of reactive oxygen species (ROS) through direct or indirect mechanisms. High ROS levels are generally detrimental to cells, and the redox status of cancer cells usually differs from that of normal cells. Because of metabolic and signalling aberrations, cancer cells exhibit elevated ROS levels. The observation that this is balanced by an increased antioxidant capacity suggests that high ROS levels may constitute a barrier to tumorigenesis. However, ROS can also promote tumour formation by inducing DNA mutations and pro-oncogenic signalling pathways. These contradictory effects have important implications for potential anticancer strategies that aim to modulate levels of ROS. In this Review, we address the controversial role of ROS in tumour development and in responses to anticancer therapies, and elaborate on the idea that targeting the antioxidant capacity of tumour cells can have a positive therapeutic impact. © 2013 Macmillan Publishers Limited.-
dc.languageeng-
dc.relation.ispartofNature Reviews Drug Discovery-
dc.titleModulation of oxidative stress as an anticancer strategy-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1038/nrd4002-
dc.identifier.pmid24287781-
dc.identifier.scopuseid_2-s2.0-84889575198-
dc.identifier.volume12-
dc.identifier.issue12-
dc.identifier.spage931-
dc.identifier.epage947-
dc.identifier.eissn1474-1784-
dc.identifier.isiWOS:000327791900020-
dc.identifier.issnl1474-1776-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats